Liquisolid technique and its applications in pharmaceutics

Lipinski, 2001, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv Drug Deliv Rev, 46, 3, 10.1016/S0169-409X(00)00129-0 Stegemann, 2007, When poor solubility becomes an issue: from early stage to proof of concept, Eur J Pharm Sci, 31, 249, 10.1016/j.ejps.2007.05.110 Liversidge, 2002, Nanocrystals: resolving pharmaceutical formulation issues associated with poorly water soluble compounds Giliyar, 2006, Challenges and opportunities in oral delivery of poorly water-soluble drugs, Drug Del Technol, 6, 57 Amidon, 1999, A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm Res, 12, 413, 10.1023/A:1016212804288 Yadav, 2010, Formulation and evaluation of orodispersible liquisolid compacts of aceclofenac, Indian J Pharm Educ, 44, 227 Aguiar, 1979, Deaggregation behavior of a relatively insoluble substituted benzoic acid and its sodium salt, J Pharm Sci, 56, 1243, 10.1002/jps.2600561006 Craig, 2002, The mechanisms of drug release from solid dispersions in water-soluble polymers, Int J Pharm, 231, 131, 10.1016/S0378-5173(01)00891-2 Ebert, 1977, Soft gelatin capsules: unique dosage form, Pharm Tech, 1, 44 Hiremath, 2008, Dissolution enhancement of gliclazide by preparation of inclusion complexes with β-cyclodextrin, Asian J Pharm, 2, 73, 10.4103/0973-8398.41572 Li, 2008, Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray-drying technique, Int J Pharm, 355, 277, 10.1016/j.ijpharm.2007.12.020 Kocbek, 2006, Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs, Int J Pharm, 312, 179, 10.1016/j.ijpharm.2006.01.008 Mahmoud, 2014, Solubility and dissolution enhancement of tadalafil using self-nanoemulsifying drug delivery system, J Oleo Sci, 63, 567, 10.5650/jos.ess13236 Müller, 2006, Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN®) versus drug nanocrystals, Int J Pharm, 317, 82, 10.1016/j.ijpharm.2006.02.045 Javadzadeh, 2009, Effect of some commercial grades of microcrystalline cellulose on flowability, compressibility, and dissolution profile of piroxicam liquisolid compacts, Drug Dev Ind Pharm, 35, 243, 10.1080/03639040802277672 Elkordy, 2013, Spironolactone release from liquisolid formulations prepared with Capryol™ 90, Solutol® HS-15 and Kollicoat® SR 30 D as non-volatile liquid vehicles, Eur J Pharm Biopharm, 83, 203, 10.1016/j.ejpb.2012.08.004 Suliman, 2014, Norfloxacin as a model hydrophobic drug with unique release from liquisolid formulations prepared with PEG 200 and Synperonic PE/L-61 non-volatile liquid vehicles, Powder Technol, 257, 156, 10.1016/j.powtec.2014.02.048 Spireas, 1999 Spireas, 2002 Spireas, 1992, Powdered solution technology: principles and mechanism, Pharm Res, 9, 1351, 10.1023/A:1015877905988 Spireas, 1998, Enhancement of prednisolone dissolution properties using liquisolid compacts, Int J Pharm, 166, 177, 10.1016/S0378-5173(98)00046-5 Fahmy, 2008, Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation, Eur J Pharm Biopharm, 69, 993, 10.1016/j.ejpb.2008.02.017 Komala, 2015, Competence of raloxifene hydrochloride loaded liquisolid compacts for improved dissolution and intestinal permeation, J Drug Deliv Sci Technol, 30, 232, 10.1016/j.jddst.2015.10.020 Sanka, 2014, Improved oral delivery of clonazepam through liquisolid powder compact formulations: in-vitro and ex-vivo characterization, Powder Technol, 256, 336, 10.1016/j.powtec.2014.02.026 Javadzadeh, 2008, Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices, Int J Pharm, 362, 102, 10.1016/j.ijpharm.2008.06.022 Nokhodchi, 2010, Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release, Colloids Surf B Biointerfaces, 79, 262, 10.1016/j.colsurfb.2010.04.008 Pavani, 2013, Liquisolid technique based sustained release tablet of trimetazidine dihydrochloride, Drug Invention Today, 5, 302, 10.1016/j.dit.2013.08.006 El-Hammadi, 2012, Investigating the use of liquisolid compacts technique to minimize the influence of pH variations on loratadine release, AAPS PharmSciTech, 13, 53, 10.1208/s12249-011-9719-6 Badawy, 2016, Use of biorelevant media for assessment of a poorly soluble weakly basic drug in the form of liquisolid compacts: in vitro and in vivo study, Drug Deliv, 23, 818, 10.3109/10717544.2014.917442 Khames, 2013, Liquisolid technique: a promising alternative to conventional coating for improve ment of drug photostability in solid dosage forms, Drug Deliv, 10, 1335 Javadzadeh, 2007, An investigation of physicochemical properties of piroxicam liquisolid compacts, Pharm Dev Technol, 12, 337, 10.1080/10837450701247574 Javadzadeh, 2007, Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties, Acta Pharm, 57, 99, 10.2478/v10007-007-0008-6 Chella, 2014, Preparation and characterization of liquisolid compacts for improved dissolution of telmisartan, J Drug Deliv, 2014, 1, 10.1155/2014/692793 Tayel, 2008, Improvement of dissolution properties of carbamazepine through application of the liquisolid tablet technique, Eur J Pharm Biopharm, 69, 342, 10.1016/j.ejpb.2007.09.003 Gubbi, 2010, Formulation and characterization of atorvastatin calcium liquisolid compacts, Asian J Pharm Sci, 5, 50 Karmarkar, 2010, Evaluation of in vitro dissolution profile comparison methods of sustained release tramadol hydrochloride liquisolid compact formulations with marketed sustained release tablets, Drug Discov Ther, 4, 26 Singh, 2012, Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique, Drug Dev Ind Pharm, 38, 961, 10.3109/03639045.2011.634810 Javadzadeh, 2007, Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine), Int J Pharm, 341, 26, 10.1016/j.ijpharm.2007.03.034 Charman, 2003, Oral modified release delivery systems, 1 Saeedi, 2011, Enhancement of dissolution rate of indomethacin using liquisolid compacts, Iran J Pharm Res, 10, 25 Karmarkar, 2009, Dissolution rate enhancement of fenofibrate using liquisolid tablet technique, Lat Am J Pharm, 28, 219 Hentzschel, 2011, Suitability of various excipients as carrier and coating materials for liquisolid compacts, Drug Dev Ind Pharm, 37, 1200, 10.3109/03639045.2011.564184 Nokhodchi, 2011, Drug release from liquisolid systems: speed it up, slow it down, Expert Opin Drug Deliv, 8, 191, 10.1517/17425247.2011.548801 Fuji Chemical Industry Co., Ltd. Fuji Chemical Industry Co., Ltd. Vranikova, 2015, Determination of flowable liquid retention potential of aluminometasilicate carrier for liquisolid systems preparation, Pharm Dev Technol, 20, 839, 10.3109/10837450.2014.926921 Hentzschel, 2012, Enhancement of griseofulvin release from liquisolid compacts, Eur J Pharm Biopharm, 80, 130, 10.1016/j.ejpb.2011.08.001 Speybroeck, 2010, Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica, Eur J Pharm Sci, 41, 623, 10.1016/j.ejps.2010.09.002 Chen, 2013, Hollow mesoporous silicas as a drug solution delivery system for insoluble drugs, Powder Technol, 240, 48, 10.1016/j.powtec.2012.07.008 Gavali, 2011, Liquisolid compact: a new technique for enhancement of drug dissolution, Int J Res Pharm Chem, 1, 705 Yadav, 2009, Improvement of solubility and dissolution of indomethacin by liquisolid and compaction granulation technique, J Pharm Sci Res, 1, 44 Adibkia, 2014, Effect of solvent type on retardation properties of diltiazem HCl form liquisolid tablets, Colloids Surf B Biointerfaces, 113, 10, 10.1016/j.colsurfb.2013.08.017 Chellaa, 2012, Use of the liquisolid compact technique for improvement of the dissolution rate of valsartan, Acta Pharm Sin B, 2, 502, 10.1016/j.apsb.2012.07.005 Vittal, 2012, Formulation and characterization of ketoprofen liquisolid compacts by Box-Behnken design, Int J Pharm Investig, 2, 150, 10.4103/2230-973X.104398 Bonthagarala, 2015, Enhancement of dissolution rate of clofibrate (BCS Class – II drug) by using liquisolid compact technology, Int J Biomed Adv & Res, 6, 288, 10.7439/ijbar.v6i3.1891 Pezzini, 2016, Liquisolid technology applied to pellets: evaluation of the feasibility and dissolution performance using felodipine as a model drug, Chem Eng Res Des, 10.1016/j.cherd.2016.01.037 Khan, 2015, Enhancement of dissolution rate of class II drugs (hydrochlorothiazide); a comparative study of the two novel approaches; solid dispersion and liquid-solid techniques, Saudi Pharm J, 23, 650, 10.1016/j.jsps.2015.01.025 Khaled, 2001, In vivo evaluation of hydrochlorothiazide liquisolid tablets in beagle dogs, Int J Pharm, 222, 1, 10.1016/S0378-5173(01)00633-0 Nokhodchi, 2005, The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts, J Pharm Sci, 8, 18 Yadav, 2009, Liquisolid granulation technique for tablet manufacturing: an overview, J Pharm Res, 2, 670 Lu, 2016, Dissolution enhancement of tadalafil by liquisolid technique, Pharm Dev Technol Elkordy, 2012, Liquisolid technique to enhance and to sustain griseofulvin dissolution: effect of choice of non-volatile liquid vehicles, Int J Pharm, 434, 122, 10.1016/j.ijpharm.2012.05.072 Gonjari, 2009, Evaluation of in vitro dissolution profile comparison methods of sustained release tramadol hydrochloride liquisolid compact formulations with marketed sustained release tablets, Dig J Nanomater Bios, 4, 651 Khanfar, 2014, Preparation of sustained-release dosage form of Venlafaxine HCl using liquisolid technique, Pharm Dev Technol, 19, 103, 10.3109/10837450.2012.757785 Ramenskaia, 2011, The dissolution test in biorelevant media as a prognostic tool for modeling of drug behavior in vivo, Biomed Khim, 57, 482, 10.18097/pbmc20115705482 Tonnensen, 2001, Formulation and stability testing of photolabile drugs, Int J Pharm, 225, 1, 10.1016/S0378-5173(01)00746-3